'Irish drug approvals remain turgid with little transparency'

The knowledge that treatment exists, but isn’t available to you, is likely to become more common, writes Susan Mitchell

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
26th July, 2017

As pharma companies in Ireland grow impatient over our lethargic and bureaucratic medicine approvals process, their counterparts in the UK are going to court in an attempt to stop the NHS from imposing new limits on the price it will pay for medicines.

The unprecedented legal action follows a new rule that allows the NHS to consider delaying or restricting funding for medicines already deemed good value for money by the drug assessment body -...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Private rental sector remains strong despite Covid-19

How the programme for government will shape housing

Insight Niall Byrne 5 months ago

Comment: US must defuse Covid-19’s ticking time bomb of debt

Insight Todd G Buchholz 6 months ago

Comment: The recovery will be more U than V-shaped

Insight Larry Hatheway 6 months ago